Home - Products - Others - Other Targets - 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide

4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide

CAS No. 757251-39-1

4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide( —— )

Catalog No. M35891 CAS No. 757251-39-1

4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide is an aromatic enigma that is is a metabolite of the antitumor drug rafenil.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 44 In Stock
50MG 62 In Stock
100MG 93 In Stock
200MG Get Quote In Stock
500MG 228 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide
  • Note
    Research use only, not for human use.
  • Brief Description
    4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide is an aromatic enigma that is is a metabolite of the antitumor drug rafenil.
  • Description
    4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide is an aromatic enigma that is is a metabolite of the antitumor drug rafenil.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Drug Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    757251-39-1
  • Formula Weight
    261.25
  • Molecular Formula
    C13H12FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CNC(=O)c1cc(Oc2ccc(N)c(F)c2)ccn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Psoralen

    Psoralen is used as photochemical probe in studies of DNA mutation and repair mechanisms. Causes photosensitization in human.

  • 9-Methoxycanthin-6-o...

    9-Methoxycanthin-6-one has anti-tumour activity, exhibits cytotoxic activity towards KB, LU-1, LNCaP, HL-60 cancer cells and other human cancer cell lines with IC50 values around 1-4 μg/mL.

  • FGH-10019

    FGH-10019 is a novel inhibitor of sterol regulatory element-binding protein (SREBP) ( IC50 :1 μM).